These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 32555376)

  • 21. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
    Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
    FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
    Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K
    Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
    Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
    J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulation of Yorkie, YAP and TAZ: new insights into the Hippo pathway.
    Manning SA; Kroeger B; Harvey KF
    Development; 2020 Apr; 147(8):. PubMed ID: 32341025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine.
    Barry ER; Simov V; Valtingojer I; Venier O
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hippo signaling in regeneration and aging.
    Elster D; von Eyss B
    Mech Ageing Dev; 2020 Jul; 189():111280. PubMed ID: 32512018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
    Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
    PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YAPping about and not forgetting TAZ.
    Callus BA; Finch-Edmondson ML; Fletcher S; Wilton SD
    FEBS Lett; 2019 Feb; 593(3):253-276. PubMed ID: 30570758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
    Zhao B; Lei QY; Guan KL
    Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. YAP‑mediated crosstalk between the Wnt and Hippo signaling pathways (Review).
    Jiang L; Li J; Zhang C; Shang Y; Lin J
    Mol Med Rep; 2020 Nov; 22(5):4101-4106. PubMed ID: 33000236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Hippo Signaling Pathway in Pancreatic Cancer.
    Ansari D; Ohlsson H; Althini C; Bauden M; Zhou Q; Hu D; Andersson R
    Anticancer Res; 2019 Jul; 39(7):3317-3321. PubMed ID: 31262852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway.
    Chan P; Han X; Zheng B; DeRan M; Yu J; Jarugumilli GK; Deng H; Pan D; Luo X; Wu X
    Nat Chem Biol; 2016 Apr; 12(4):282-9. PubMed ID: 26900866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the Hippo Pathway for Anti-cancer Therapies.
    Gong R; Yu FX
    Curr Med Chem; 2015; 22(35):4104-17. PubMed ID: 26429069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
    Chai J; Xu S; Guo F
    Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
    Shreberk-Shaked M; Oren M
    Mol Oncol; 2019 Jun; 13(6):1335-1341. PubMed ID: 31050214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Hippo pathway in normal development and cancer.
    Maugeri-Saccà M; De Maria R
    Pharmacol Ther; 2018 Jun; 186():60-72. PubMed ID: 29305295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Hippo pathway in intestinal regeneration and disease.
    Hong AW; Meng Z; Guan KL
    Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):324-37. PubMed ID: 27147489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway.
    Mo JS; Meng Z; Kim YC; Park HW; Hansen CG; Kim S; Lim DS; Guan KL
    Nat Cell Biol; 2015 Apr; 17(4):500-10. PubMed ID: 25751140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration.
    Wang J; Liu S; Heallen T; Martin JF
    Nat Rev Cardiol; 2018 Nov; 15(11):672-684. PubMed ID: 30111784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.